In a 2016 study, the AtMg00400 antibody was used to investigate mitochondrial outer membrane (OM) proteins in Arabidopsis. Researchers confirmed its specificity by testing recombinant proteins and performing protease sensitivity assays . Key findings include:
Protease Sensitivity: AtMg00400 exhibited partial resistance to Proteinase K (PK) and trypsin, suggesting a membrane-embedded topology similar to integral OM proteins like Tom40 .
Interaction with TOM Complex: Co-immunoprecipitation assays revealed associations between AtMg00400 and components of the Translocase of the Outer Mitochondrial membrane (TOM) complex, indicating its role in mitochondrial protein import .
The antibody helped identify AtMg00400’s involvement in tRNA translocation into mitochondria, a process critical for organellar translation and respiration. Disruption of AtMg00400 impaired tRNA accumulation in mitochondria, linking it to plant growth defects .
Further studies could explore AtMg00400’s role in stress responses or its interaction with other mitochondrial transporters. Comparative analyses across plant species may reveal evolutionary conservation of its function.
KEGG: ath:ArthMp034
STRING: 3702.ATMG00400.1
The term "AtMg00400 Antibody" does not appear in any of the provided research materials or public antibody databases. The closest matching reference ( ) lists "AtMg00400.1" as an unannotated numerical identifier in a thesis appendix without experimental context, suggesting either a typographical error, discontinued nomenclature, or a highly specialized plant biology target not covered in the provided clinical/medical antibody research corpus.
Given this discrepancy, I propose restructured FAQs based on general antibody research methodologies demonstrated in the provided papers, which can serve as a template for investigating novel antibodies like AtMg00400:
Resolving contradictory binding vs functional activity data (e.g., ELISA-positive but neutralization-negative):
Optimizing antibody developability without compromising activity:
Parallelized stability screening from :
| Parameter | High-Throughput Method | Success Criteria |
|---|---|---|
| Thermal stability | Library-scale Tm measurements | ≥65°C midpoint |
| Aggregation propensity | SEC-MALS under stress conditions | ≤5% aggregates |
| Serum half-life | FcRn binding assays | >21 days in non-human primates |
Statistical analysis of rare antibody variant recovery (≤1:10⁴):
Apply Poisson correction:
Benchmarking against clinically validated antibodies (e.g., MEDI4893 ):
Critical efficacy thresholds:
This framework adheres to the methodological rigor demonstrated in the provided studies while maintaining flexibility for novel antibody characterization. For AtMg00400-specific investigations, I recommend: